Traditional Chinese Medicine Suppresses Left Ventricular Hypertrophy by Targeting Extracellular Signal-Regulated Kinases Signali

Total Page:16

File Type:pdf, Size:1020Kb

Traditional Chinese Medicine Suppresses Left Ventricular Hypertrophy by Targeting Extracellular Signal-Regulated Kinases Signali Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal- regulated kinases signaling pathway in spontaneously hypertensive rats The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Xiong, Xingjiang, Xiaochen Yang, Lian Duan, Wei Liu, Yun Zhang, Yongmei Liu, Pengqian Wang, Shengjie Li, and Xiaoke Li. 2017. “Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats.” Scientific Reports 7 (1): 42965. doi:10.1038/srep42965. http:// dx.doi.org/10.1038/srep42965. Published Version doi:10.1038/srep42965 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:32072070 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA www.nature.com/scientificreports OPEN Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting Received: 10 October 2016 Accepted: 17 January 2017 extracellular signal-regulated Published: 22 February 2017 kinases signaling pathway in spontaneously hypertensive rats Xingjiang Xiong1, Xiaochen Yang1, Lian Duan1, Wei Liu2, Yun Zhang3, Yongmei Liu3, Pengqian Wang4, Shengjie Li5 & Xiaoke Li6 Chinese herbal medicine Bu-Shen-Jiang-Ya decoction (BSJYD) is reported to be beneficial for hypertension. Over expression of extracellular signal regulated kinases (ERK) pathway plays an important role in left ventricular hypertrophy (LVH). This study aimed to observe effects of BSJYD on LVH in spontaneously hypertensive rats (SHRs) and explore its possible mechanism on regulation of ERK pathway. Sixty 12-week-old SHRs were randomly allocated into 5 groups: BSJYD high dose group, middle dose group, low dose group, captopril group, and control group. Besides, a control group of Wistar-Kyoto rats was established. All rats were treated for 8 weeks. Systolic blood pressure (SBP), heart rate (HR), pathology, and left ventricular mass index (LVMI) were measured. Western blotting and Real-time PCR were used to assess the expressions of BDNF, Ras, ERK1/2, and c-fox levels. SBP and HR were significantly decreased compared with the control group and LVMI was markedly improved by BSJYD treatment in a dose-dependent manner. BSJYD inhibited the expression of BDNF, Ras, ERK1/2, and c-fox mRNA in LVH. In conclusion, BSJYD suppressed hypertension-induced cardiac hypertrophy by inhibiting the expression of ERK pathway. These changes in gene expression may be a possible mechanism by which BSJYD provides myocardial protection from hypertension. Hypertension is an important worldwide public health challenge because of its high prevalence and concomitant increase in risks of cardiovascular, cerebrovascular and renal diseases1,2. It has been identified as the leading risk factor for mortality in human populations, and is ranked third as a cause of disability-adjusted life-years3,4. Hypertension is not only manifested by an elevated arterial blood pressure (BP), but also involves complex struc- tural and functional alterations of its target organs5. In the hypertensive state, a number of adaptive changes occur in ventricle. Cardiac hypertrophy results from increased mechanical load on the heart and through the action of neurohumoral mediators. Left ventricular hypertrophy (LVH) is a cardinal manifestation of hypertensive organ damage associated with an increased cardiovascular morbidity and mortality6,7. LVH in hypertensive patients may be regarded as a powerful, independent biomarker reflecting the impact of pressure overload as well as of several risk factors on heart8. These structural abnormalities may play an important role in the development and 1Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. 2Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China. 3Department of Molecular Biology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. 4Department of Pharmacology, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. 5Department of Molecular Biology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. 6Bio-organic and Natural Products Laboratory, McLean Hospital, Harvard Medical School, Belmont, USA. Correspondence and requests for materials should be addressed to X.X. (email: [email protected]) SCIENTIFIC REPORTS | 7:42965 | DOI: 10.1038/srep42965 1 www.nature.com/scientificreports/ Group n 0 week 4 weeks 8 weeks WKY 12 120.71 ± 8.79**▲▲ 125.98 ± 9.08**▲▲ 126.77 ± 8.54** C 12 201.73 ± 9.43 212.63 ± 8.16▲▲ 218.65 ± 9.72▲▲ Ca 12 200.66 ± 10.56 164.77 ± 8.52** 170.28 ± 10.12** Bh 12 202.27 ± 9.06 184.37 ± 10.35**▲ 178.13 ± 8.76** Bm 12 201.54 ± 10.06 193.03 ± 9.89▲ 188.04 ± 7.86**▲ Bl 12 200.81 ± 9.32 190.17 ± 8.91▲ 190.65 ± 9.79**▲ Table 1. Effect of Bu-Shen-Jiang-Ya decoction on systolic blood pressure. *P < 0.05, **P < 0.01, significantly different from the C group. ▲P < 0.05, ▲▲P <​ 0.01, significantly different from the Ca group. Group n 0 week 4 weeks 8 weeks WKY 12 366.74 ± 26.83**▲▲ 345.91 ± 25.42**▲▲ 331.77 ± 27.92** C 12 412.89 ± 19.56 396.26 ± 23.83▲▲ 370.51 ± 23.91▲▲ Ca 12 408.36 ± 20.72 391.88 ± 22.61 361.69 ± 20.07 Bh 12 402.52 ± 24.07 376.63± 23.01*▲ 344.43 ± 18.93**▲ Bm 12 399.25 ± 25.80 394.42 ± 22.80 383.74 ± 27.03▲ Bl 12 405.48 ± 21.84 391.37 ± 18.02 387.45 ± 23.91▲▲ Table 2. Effect of Bu-Shen-Jiang-Ya decoction on heart rate. *P < 0.05, **P <​ 0.01, significantly different from the C group. ▲P < 0.05, ▲▲P <​ 0.01, significantly different from the Ca group. maintenance of hypertension, because they may eventually lead to decompensation and ventricular extension, thus increasing the risk of heart failure and sudden death. Studies have confirmed that, with the development of LVH, the incidence of cardiovascular events has increased by 6–10 times9–12. Therefore, suppression of LVH was shown to improve cardiovascular outcome independently of other risk factors, and thus has been suggested as an intermediate endpoint13,14. The mitogen-activated protein kinases (MAPKs) have been implicated as focal mediators of cardiac hyper- trophy in both cell culture and genetically modified mouse models15. The extracellular signal-regulated kinase (ERK) signaling pathway, a branch of the greater MAPK signaling cascade, appears to induce a unique form of concentric cardiac hypertrophy16. It is activated in response to almost every stress- and agonist-induced hyper- trophic stimulus examined to date, suggesting the straightforward hypothesis that these kinases are required for promoting the cardiac growth response17. Signaling through ERK cascade is classically initiated at the cell membrane by activation of the small G protein Ras that then recruits the MAP3K Raf-1 to the plasma membrane, where it is activated18. More and more evidences showed that over expression of ERK signaling pathway plays an important role in cardiac hypertrophy19–21. Traditional Chinese medicine (TCM) has been reported to be effective for the treatment of hyperten- sion22–24. However, there was little information available in literature about whether Chinese herbal medicine with anti-hypertensive effect could affect ERK pathway in LVH. Herbal compounds Bu-Shen-Jiang-Ya decoction (BSJYD) has been widely used in treating hypertension with kidney yin deficiency syndrome for many years. In our previous study, a prospective case series involving 108 hypertensive patients with kidney yin deficiency syn- drome revealed a significant reduction of 13.1 mmHg of systolic blood pressure (SBP) and 9.30 mmHg of diastolic blood pressure (DBP) by BSJYD25. Additionally, no acute toxicology was identified on mice26. The significant BP-lowering effect of BSJYD has been confirmed in spontaneously hypertensive rats (SHRs); moreover, the pos- sible cardioprotective mechanisms of BSJYD on hypertension may be related to up-regulating adiponectin and improving insulin resistance27. However, further study of its detailed anti-hypertensive and reversing ventricular hypertrophy mechanism is still needed. Here, we aimed to examine how ERK signal transduction induces LVH and whether BSJYD inhibits LVH bioactivities through the ERK signaling pathway effectively. Results Effect of BSJYD on SBP. After treatment for 8 weeks, SBP was significantly decreased in the Ca group, the Bh group, the Bm group, and the Bl group compared with the C group (P <​ 0.05). Compared with the Ca group, SBP was significantly increased in the Bm group, the Bl group, and the C group (P <​ 0.05), while no significant differences were identified between the Ca group and Bh group (P >​ 0.05) (as shown in Table 1). Effect of BSJYD on HR. As shown in Table 2, HR were significantly lowered after 8 weeks in the Bh group (P <​ 0.01), while HR in the Bm group, the Bl group, and the Ca group were not significantly lowered when com- pared to the C group. As compared with the Ca group, the Bh group was significantly lowered (P < 0.05), while there is no significantly difference in the other groups (P > 0.05). Effect of BSJYD on LVMI. After treatment for 8 weeks, LVMI in the WKY group, the Ca group, and the Bh group were significantly lowered when compared to the C group (P <​ 0.05). However, no significant difference between the Ca group and Bh group was identified (Fig. 1). SCIENTIFIC REPORTS | 7:42965 | DOI: 10.1038/srep42965 2 www.nature.com/scientificreports/ Figure 1. Effect of Bu-Shen-Jiang-Ya decoction on left ventricular mass index. *P < 0.05, **P < 0.01, significantly different from the C group.
Recommended publications
  • HERBAL SUPPORT for CANCER PATIENTS by John Heuertz, DOM
    HERBAL SUPPORT FOR CANCER PATIENTS By John Heuertz, DOM One of the most widely studied and accepted uses of Chinese herbs among modern medical treatments is Fu Zheng Pei Ben (FZPB) therapy in adjuvant cancer treatment. “Fu Zheng” re- fers to the support of the body’s normal healthy qi, the “Zheng qi”; “Pei Ben” refers to the stra- tegic reinforcement of the body’s ability to fight specific disease manifestations. When used in combination with proven modern medical treatments for cancer—specifically, chemotherapy, radiotherapy, and surgery—FZPB can minimize clinical side effects and facilitate recovery. This guide is intended to assist qualified licensed Oriental Medicine (OM) practitioners in supporting patients with cancer. Please Note: Though the Materia Medicae of OM lists herbs that can break up masses and herbs which posses anti-neoplastic actions, the formulas discussed in this paper are neither designed nor intended to “cure cancer” per se, nor to be employed as the primary treatment for a patient with can- cer. Use this guide to assist your selection of the right FZPB strategy. Be sure the patient receives regular assessments by a qualified medical doctor. OVERVIEW OF FZPB THERAPY IN THE TREATMENT OF CANCER Oriental Medicine and western medicine agree that cancerous tumors are a localized manifestation of a pathology that exists in the entire body. This pathology can result from exposure to toxins such as radia- tion or carcinogenic chemicals, or owing to exogenous pathogens, a malfunctioning immune system or immunodeficiency, poor nutrition, hereditary tendencies, weakness or damage to the organs, prolonged qi and/or blood stagnation, prolonged blood or yin deficiency, emotional factors, and more.
    [Show full text]
  • Traditional Chinese Medicine
    中醫 施今墨對藥 中醫基礎 中西醫結合 Traditional Chinese Medicine SHI JIN MO DUI YAO 5 TCM Principles Integrated Traditional & 2 Multiple Sclerosis (MS) - A 5 Art of Combining Western Medicine Chinese Medicine Perspective Medicinals According to 7 Getting Results in Multiple Master Shi Jin Mo Sclerosis Management 研究 質量 安全 Research, Quality, safty and Efficacy CONTENTS 10 Sun Ten Ginseng-Premium six Years Old Ginseng 中醫 TRADITIONAL CHINESE MEDICINE Multiple Sclerosis (MS) – A Chinese Medicine Perspective Signs and Symptoms nourish kidney and liver yin, transform • Weakness and loss of muscle phlegm and move blood. • co-ordination Over time, kidney yin vacuity is likely to • Tingling, numbness, dizziness change into a vacuity of both yin and yang. • Blurred vision Thus, herbs are added that supplement • Pain yang. Also, more stasis moving herbs may • Heat sensitivity be needed, including herbs that move liver • Loss of bladder control qi. As stasis may transform into heat, heat • Memory loss, problem-solving clearing herbs may also be added. difficulties • Mood disturbances Theory behind the symptoms The liver stores blood and opens at the eyes; hence there is a strong connection Multiple sclerosis (MS) is an unpredictable Western Drug Therapies between the state of the liver and the state disease of the nervous system in which Your patient may already take the following of the eyes. Liver yin/blood vacuity may communication between the brain and Western Medication: impair vision. other parts of the body is disrupted. Its • Steroids with anti-inflammatory effects can range from relatively mild properties (e.g. prednisone) to reduce Blood and yin deficiency may give rise to devastating.
    [Show full text]
  • Liu Wei Di Huang
    Chinese Herbal Formulas and Applications Section 4 補陰劑 — Yin-Tonifying Formulas Liù Wèi Dì Huáng Wán (Six-Ingredient Pill with Rehmannia) 六味地黃丸 六味地黃丸 8 Pinyin Name: Liu Wei Di Huang Wan Literal Name: Six-Ingredient Pill with Rehmannia Alternate Names: Liu Wei Ti Huang Wan, Di Huang Wan, Six-Flavour Rehmannia Pill, Rehmannia Bolus with Six Herbs, Rehmannia Six Pill, Rehmannia Six Formula Original Source: Xiao Er Yao Zheng Zhi Jue (Craft of Medicinal Treatment for Childhood Disease Patterns) by Qian Yi in 1119 TONIC FORMULAS COMPOSITION Shu Di Huang (Radix Rehmanniae Praeparata) 240g [24g] Shan Zhu Yu (Fructus Corni) 120g [12g] Shan Yao (Rhizoma Dioscoreae) 120g [12g] Ze Xie (Rhizoma Alismatis) 90g [9g] Mu Dan Pi (Cortex Moutan) 90g [9g] Fu Ling (Poria) 90g [9g] DOSAGE / PREPARATION / ADMINISTRATION 2. Yin-deficient heat: steaming bones sensations, heat sensa- Grind the ingredients into powder and form into small tions in the palm and soles, tidal fever, thirst, toothache, pills with honey. The pills should resemble the size of Wu a dry mouth and throat, a red tongue body with a scanty Tong Zi (Semen Firmianae), a small seed approximately tongue coating, and a fine, rapid pulse. Can also be used 5 mm in diameter. Take the pills on an empty stomach for xiao ke (wasting and thirsting) syndrome. three times daily with warm water. Today, it is usually prepared in pill form by mixing the powdered herbs with CLINICAL APPLICATIONS honey. Each pill should weigh approximately 15g. Take 1 Diabetes mellitus, menopause, coronary heart disease, pill three times daily on an empty stomach with warm, hypertension, hyperthyroidism, hypothyroidism, thyroid boiled water.
    [Show full text]
  • Traditional Chinese Medicine—–What Are We Investigating? the Case of Menopauseଝ
    Complementary Therapies in Medicine (2007) 15, 54—68 Traditional Chinese medicine—–What are we investigating? The case of menopauseଝ Volker Scheid ∗ School of Integrated Health, University of Westminster, 115 New Cavendish Street, Westminster, London W1W 6UW, United Kingdom Available online 9 February 2006 KEYWORDS Summary CAM researchers commonly treat traditional medicines as unchang- Traditional Chinese ing systems. This article questions the validity of this approach by examining the medicine; treatment of menopausal syndrome by traditional Chinese medicine (TCM). Such Kampo; treatment strategies were invented in 1964 and betray a strong influence of biomed- Traditional medicine; ical thinking. While they determine TCM treatment of menopausal syndrome in the Menopause; West, physicians in China and Japan use many other treatment strategies from within the wider Chinese medical tradition in clinical practice. Cultural variability in the Research design; manifestation of menopausal syndrome furthermore questions the usefulness of sim- Medical anthropology; ply importing treatment strategies from China to the West. This leads me to conclude History of medicine that Chinese medicine as such can never be evaluated by means of clinical research. What we can do is use Chinese medicine as a resource for thinking about illness, and for formulating clinical interventions that may then be assessed using methods of evidence based research. © 2006 Published by Elsevier Ltd. Introduction ous efforts to find alternatives. This specifically includes the integration of complementary and Eighty percent of women in the UK experience alternative medicines (CAM) into treatment proto- menopausal symptoms and 45% find the symp- cols tailored to women’s individual needs.1—3 toms distressing.1 An increasing awareness among Traditional Chinese medicine (TCM) appears to both health care providers and patients regarding be a fruitful area to which such efforts might be potential adverse effects associated with hormone directed.
    [Show full text]
  • Research Article Chinese Patent Medicine Liu Wei Di
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 714805, 7 pages doi:10.1155/2012/714805 Research Article Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials Jie Wang,1 Kuiwu Yao,1 Xiaochen Yang,1 Wei Liu, 1 Bo Feng,1 Jizheng Ma,2 Xinliang Du,3 Pengqian Wang,4 and Xingjiang Xiong1 1 Department of Cardiology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 2 Department of Gastroenterology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 3 Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China 4 Department of Endocrinology, Traditional Chinese Medicine Hospital of Mentougou District, Beijing 102300, China Correspondence should be addressed to Xingjiang Xiong, [email protected] Received 26 August 2012; Accepted 10 October 2012 Academic Editor: Vassya Bankova Copyright © 2012 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objectives. To assess the beneficial and adverse effects of Liu Wei Di Huang Wan (LWDHW), combined with antihypertensive drugs, for essential hypertension. Methods. Five major electronic databases were searched up to August 2012 to retrieve any potential randomized controlled trials designed to evaluate the clinical effectiveness of LWDHW combined with antihypertensive drugs for essential hypertension reported in any language, with main outcome measures as blood pressure.
    [Show full text]
  • Kan Herbals Formula Guide
    FORMULA GUIDE Chinese Herbal Products You Can Trust Kan Herbals – Formulas by Ted Kaptchuk, O.M.D. Written and researched by Ted J. Kaptchuk, O.M.D.; Z’ev Rosenberg, L.Ac. Copyright © 1992 by Sanders Enterprises with revisions of text and formatting by Kan Herb Company. Copyright © 1996 by Andrew Miller with revisions of text and formatting by Kan Herb Company. Copyright © 2008 by Lise Groleau with revisions of text and formatting by Kan Herb Company. All rights reserved. No part of this written material may be reproduced or stored in any retrieval system, by any means – photocopy, electronic, mechanical or otherwise – for use other than “fair use,” without written consent from the publisher. Published by Golden Mirror Press, California. Printed in the United States of America. First Edition, June 1986 Revised Edition, October 1988 Revised Edition, May 1992 Revised Edition, November 1994 Revised Edition, April 1996 Revised Edition, January 1997 Revised Edition, April 1997 Revised Edition, July 1998 Revised Edition, June 1999 Revised Edition, June 2002 Revised Edition, July 2008 Revised Edition, February 2014 Revised Edition, January 2016 FORMULA GUIDE 25 Classical Chinese Herbal Formulas Adapted by Ted Kaptchuk, OMD, LAc Contents Product Information.....................................................................................................................................1 Certificate of Analysis Sample .................................................................................................................6 High Performance
    [Show full text]
  • Oriental Medicine Doctoral Programs
    SPRING 2017 www.pacificcollege.edu A Brief History of Acupuncture and Oriental Medicine Doctoral Programs doctorate in acupuncture and Oriental medicine has been a goal of the profession since its beginnings in the late 1970s. A At that time, however, the maturity of the educational institu- tions and the regulatory environment made it a goal with only a dis- tant completion date. Throughout the 1990s, the colleges continually increased their expertise and resources and the doctoral project gath- ered momentum. Finally, by May 2000, standards for the post-graduate doctorate, the Doctor of Acupuncture and Oriental Medicine (DAOM), were approved by the Accreditation Commission of Acupuncture and Oriental Medicine (ACAOM). Entrance to the DAOM required a mas- ter’s degree in acupuncture and Oriental medicine. continued on page 4 The 5 Phases of Event Training INSIDE THIS ISSUE.... PAID PRSRT STD PRSRT U.S. POSTAGE Bolingbrook, IL PERMIT NO.932 Using Sports Acupuncture 3 Teaching is a Healing Art 4 TCM for Diabetes Mellitus Insights of a TCM Dermatologist By ERIN HURME, DAOM 10 10 Citrus and Pinellia: Loyalty, Simplicity and Integrity hen treating athletes, to ensure the treatments hold and 11 Table Thai Massage vs. Floor there are many things to the athlete can maintain their per- Thai Massage: You’re Asking W take into consideration formance and reach their goals. Ath- the Wrong Question and timing is one of the most critical. letes tend to reinjure their body in 12 Yin and Yang Most athletes participate in scheduled the same location again and again. events that they prepare for months This can vary slightly depending on 14 Herbal Treatment in Special in advance.
    [Show full text]
  • Five Cases of Depleted Yin
    feature Five cases of depleted yin ByNghiaThanhTran I remember reading a quote from Ante Babic in The Lantern. In writing about Traditional Chinese medicine has turned a big corner in the last practising TCM, he wrote: “I think, therefore I am wrong.”1 This is so true, and I believe century. Such was the turn that now we can barely see the road that serious TCM practitioners think behind. Personal experiences handed down through generations the same way about the importance of have been wiped out by China’s whirlwind cultural revolution, while intuition in TCM. Intuition is not scientific, new practitioners have only a very limited number of ancient it is not measurable, not tangible and can’t be taught. Practitioners require constant textbooks to resource. self-cultivation to achieve it, and long-term practice is part of that cultivation. The health problems of today reflect the N A PoSITIVE note, Westerners are stressful way we live. We work longer hours obecoming increasingly interested in and in more stressful occupations than TCM, and information is becoming in- previous generations, and our children creasingly available. The original method work even harder than we do. Excessive of transferring experience from master to work without adequate rest leads to yin disciple has been replaced by hundreds of depletion, and this, I believe, is one of the textbooks written in English. Unfortunate- main TCM patterns of the modern world. ly, these textbooks have all evolved from Therefore, I would like to share my the same few ancient works, and subse- experiences in treating cases of depleted yin.
    [Show full text]
  • Effects of Herbal Medicine for Xerostomia in Head and Neck Cancer Patients: an Observational Study in a Tertiary Cancer Hospital
    Supportive Care in Cancer (2019) 27:3491–3498 https://doi.org/10.1007/s00520-019-4646-2 ORIGINAL ARTICLE Effects of herbal medicine for xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital Ren Jye Lim1,2 & Wan Najbah Nik Nabil1,3 & Si Yan Chan3,4 & Yoke Fui Wong5 & Li Xian Han1 & Jia Ying Gong1,3 & Kun Ling Ho1 & Yee Siang Shew6 & Li Xu2 Received: 12 July 2018 /Accepted: 14 January 2019 /Published online: 24 January 2019 # Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Purpose More than 80% head and neck cancer patients endured radiotherapy-induced xerostomia which impacts their quality of life (QoL). This observational study evaluated the effect of herbal treatment on head and neck cancer patients’ xerostomia and QoL. Methods Head and neck cancer patients were recruited from July 2016 till March 2017 at National Cancer Institute, Ministry of Health, Malaysia. All study participants continued their standard oncology surveillance. Treatment group participants addition- ally received Chinese herbal treatment. The assessments included unstimulated salivary flow rate (USFR), stimulated salivary flow rate (SSFR), and QoL questionnaire. Results Of 42 recruited participants, 28 were in the treatment group and 14 were in the control group. Participants were mainly Chinese (71.4%), stage III cancer (40.5%), and had nasopharynx cancer (76.2%). The commonly used single herbs were Wu Mei, San Qi, and Tian Hua Fen. Sha Shen Mai Dong Tang, Liu Wei Di Huang Wan, and Gan Lu Yin were the frequently prescribed herbal formulas. The baseline characteristics, USFR, SSFR, and QoL between control and treatment groups were comparable (p > 0.05).
    [Show full text]
  • Research Article Chinese Patent Medicine Liu
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 714805, 7 pages doi:10.1155/2012/714805 Research Article Chinese Patent Medicine Liu Wei Di Huang Wan Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials Jie Wang,1 Kuiwu Yao,1 Xiaochen Yang,1 Wei Liu, 1 Bo Feng,1 Jizheng Ma,2 Xinliang Du,3 Pengqian Wang,4 and Xingjiang Xiong1 1 Department of Cardiology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 2 Department of Gastroenterology, Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China 3 Graduate School, China Academy of Chinese Medical Sciences, Beijing 100700, China 4 Department of Endocrinology, Traditional Chinese Medicine Hospital of Mentougou District, Beijing 102300, China Correspondence should be addressed to Xingjiang Xiong, [email protected] Received 26 August 2012; Accepted 10 October 2012 Academic Editor: Vassya Bankova Copyright © 2012 Jie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objectives. To assess the beneficial and adverse effects of Liu Wei Di Huang Wan (LWDHW), combined with antihypertensive drugs, for essential hypertension. Methods. Five major electronic databases were searched up to August 2012 to retrieve any potential randomized controlled trials designed to evaluate the clinical effectiveness of LWDHW combined with antihypertensive drugs for essential hypertension reported in any language, with main outcome measures as blood pressure.
    [Show full text]
  • Insomnia and Anxiety
    DISTURBED SHEN (Insomnia, Anxiety, Palpitation) Jake Paul Fratkin, OMD, L.Ac. Pacific Symposium, October 2016 Classical formulas: Bai Zi Yang Xin Tang băi zĭ yǎnɡ xīn tāng (柏⼦养⼼汤) Gan Mai Da Zao Tang gān mài dà zăo tāng (⽢⻨⼤枣汤) Gui Pi Tang guī pí tāng (归脾汤) Suan Zao Ren Tang suān zăo rén tāng (酸枣仁汤) Tian Wang Bu Xin Dan tiān wáng bŭ xīn dān (天⺩补⼼丹) Modern Formulas: An Mian Pian ān mián piàn (安眠⽚ ) An Mian Wan ān mián wán (安眠丸) An Shen Bu XIn Wan ān shén bŭ xīn wán (安神补⼼丸) An Shui Wan ān shuì wán (安睡丸 ) Bu Nao Wan bŭ nǎo wán (补脑丸) /Jian Nao Wan / jiàn nǎo wán (健脑丸) The word shén (神 ) is often translated as “spirit”, and disturbed shen implies that the spirit is agitated, especially as it affects the mind and emotional stability. Symptoms and disorders include insomnia or restless sleep, anxiety, palpitation, tachycardia and heart arrhythmias, and in some cases manic behavior. Other symptoms include poor concentration, memory or forgetfulness. Disturbed shen disorders are divided between those of deficiency and those of excess. Deficiency syndromes are more common and are of two types: deficiency of both yin and blood, and deficiency of both qi and yang. In deficiency of yin and blood, deficiency-heat may lead to redness in the tip of the tongue, or the tongue may be pale. The pulse is thin and may be slightly rapid. The condition is due to over mental activity, exhaustion of jing, or deficiency of kidney yin. Symptoms include irregular heartbeat, disturbed dream-filled sleep and poor memory.
    [Show full text]
  • Therapeutic Effects of Chinese Herbal Medicine Against Neuroendocrinological Diseases Especially Related to Hypothalamus- Pituit
    Therapeutic effects of Chinese herbal medicine against neuroendocrinological diseases especially related to hypothalamus- pituitary-adrenal and hypothalamus-pituitary-gonadal axis Di Wang1,2, Cheng-Yu Lu1, Le-Sheng Teng1, Zhi-Hua Guo1, Qing-Fan Meng1, Yan Liu1, Linda LD Zhong3, Wei Wang2, Jing Xie1* and Zhang-Jin Zhang2* 1College of Life Sciences, Jilin University, Changchun, China 2School of Chinese Medicine, Faculty of Medicine, the University of Hong Kong, Hong Kong, China 3School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China Abstract: This is a systemic review of plants used traditionally for neuroendocrinological diseases related to hypothalamus-pitutary-adrenal (HPA) and hypothalamus-pitutary-gland (HPG) axis. By searching from PubMed literature search system (1950-2013), Medline (1950-2013) and CNKI (China Journals of Full-text database; 1989- 2013), 105 papers met the inclusion criteria were displayed in this review. 96 herbal drugs were classified into two parts which include hormones mainly related to HPA and HPG axis. The full scientific name of each herbal medicine, dose ranges and routes, models or diseases, affect on hormones and pertinent references are presented via synoptic tables. Herbal remedies that have demonstrable the activities of hormones have provided a potential to various diseases related to neunoendocrine and deserve increased attention in future studies. This review provides a basis for herbs use in neuroendocrinological diseases. The data collected here will benefit to further research associated to herbal medicines and hormones. Keywords: Herbal medicine, Neuroendocrinological diseases, hypothalamus-pitutary-adrenal (HPA) axis, hypothalamus-pitutary-gland (HPG) axis. INTRODUCTION adrenal (HPA) and hypothalamus-pitutary-gland (HPG) axis.
    [Show full text]